- Home
- SFWL vs JSPR Comparison
SFWL vs JSPR Comparison
Compare SFWL & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SFWL
- JSPR
- Stock Information
- Founded
- SFWL 2001
- JSPR 2018
- Country
- SFWL China
- JSPR United States
- Employees
- SFWL N/A
- JSPR N/A
- Industry
- SFWL Trucking Freight/Courier Services
- JSPR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SFWL Industrials
- JSPR Health Care
- Exchange
- SFWL Nasdaq
- JSPR Nasdaq
- Market Cap
- SFWL 74.2M
- JSPR 85.8M
- IPO Year
- SFWL 2023
- JSPR N/A
- Fundamental
- Price
- SFWL $1.02
- JSPR $5.50
- Analyst Decision
- SFWL
- JSPR Strong Buy
- Analyst Count
- SFWL 0
- JSPR 11
- Target Price
- SFWL N/A
- JSPR $62.22
- AVG Volume (30 Days)
- SFWL 10.3K
- JSPR 190.5K
- Earning Date
- SFWL 06-10-2025
- JSPR 05-12-2025
- Dividend Yield
- SFWL N/A
- JSPR N/A
- EPS Growth
- SFWL 4.79
- JSPR N/A
- EPS
- SFWL 0.13
- JSPR N/A
- Revenue
- SFWL $504,158,000.00
- JSPR N/A
- Revenue This Year
- SFWL N/A
- JSPR N/A
- Revenue Next Year
- SFWL N/A
- JSPR N/A
- P/E Ratio
- SFWL $7.72
- JSPR N/A
- Revenue Growth
- SFWL 24.75
- JSPR N/A
- 52 Week Low
- SFWL $0.81
- JSPR $3.13
- 52 Week High
- SFWL $2.15
- JSPR $26.84
- Technical
- Relative Strength Index (RSI)
- SFWL 54.75
- JSPR 62.15
- Support Level
- SFWL $0.94
- JSPR $4.57
- Resistance Level
- SFWL $1.02
- JSPR $5.90
- Average True Range (ATR)
- SFWL 0.05
- JSPR 0.38
- MACD
- SFWL -0.00
- JSPR 0.07
- Stochastic Oscillator
- SFWL 68.67
- JSPR 70.37
About SFWL Shengfeng Development Limited
Shengfeng Development Ltd is a holding company. Through its subsidiaries, it offers contract logistics services in China. The contract logistics services offered by the company include planning and designing supply chains, designing facilities, processing orders, collecting payments, managing inventories, and providing client services.
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.